Adopting Health Technologies in Israel and England.

Area of Science:

• Health Policy
• Health Technology Assessment
• Comparative Health Systems

Background:

• Global health systems face challenges in prioritizing and funding new health technologies.
• Health Technology Assessment (HTA) is crucial for informed national health policy and public coverage decisions.
• Comparing HTA processes in different countries provides insights into adoption drivers and discrepancies.

Purpose of the Study:

• To identify, analyze, and compare key considerations in medical technology adoption.
• To reflect national health policies in Israel and England concerning technology adoption.
• To understand the similarities and differences in HTA decision-making between the two nations.

Main Methods:

• Analysis of 287 Israeli pharmaceuticals approved for public funding (2020-2022).
• Comparison with England's recommendations on clinical effectiveness, economic factors, and social values.
• Comparative analysis of adoption drivers and policy considerations.

Main Results:

• A 49% agreement was found in funding recommendations between Israel and England.
• Agreement increased to 60%-65% in specialized areas like oncology, diabetes, and hematology.
• Clinical impact, added value, and social considerations were primary adoption drivers in both systems.
• Budgetary concerns were more prominent in England's decision-making.

Conclusions:

• Significant resemblance in medical technology adoption decisions between Israel and England suggests shared principles of public healthcare accountability.
• The global advancement of medical innovation and research likely influences both systems.
• Divergent economic considerations lead to policy discrepancies and tactical diversity in health technology adoption.